AUTHOREA
Log in Sign Up Browse Preprints
All Authorea-powered sites will be offline 6am-10am EDT Tuesday 11 June
for Essential Maintenance. We apologise for any inconvenience.

January 24, 2023
COST-EFFECTIVENESS OF OMALIZUMAB FOR THE TREATMENT OF SEVERE PEDIATRIC ALLERGIC ASTHM...
Antonio Nieto, María Nieto-Cid, Teresa Garriga-Baraut, et al.
October 29, 2020
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent al...
Antonio Nieto García, Teresa Garriga-Baraut, Ana Maria Plaza, et al.